At-Home Administration Support

Are you currently taking Sandostatin® LAR Depot (octreotide acetate) for injectable suspension? In light of the COVID-19 pandemic, you may be eligible to have your monthly injection given at home by a trained health care professional.

Important Safety Information

Warnings and Precautions: Treatment with Sandostatin LAR Depot may affect gallbladder function, with postmarketing reports of gallstones resulting in complications (inflammation of the gallbladder, bi...

See More
Approved Use:

Sandostatin® LAR Depot (octreotide acetate) for injectable suspension is indicated for patients in whom initial treatment with immediate-release Sandostatin® (octreotide acetate) Injection has been shown to be effective and tolerated for

  • Long-term treatment of the severe diarrhea and f...
See More
learn more about

Sandostatin LAR Depot

Sandostatin LAR Depot works by blocking the production of a number of hormones that can lead to severe diarrhea and flushing associated with carcinoid syndrome. Your doctor will identify if Sandostatin LAR Depot is right for you based on your response to, and how well you tolerate, 2 weeks of treatment with Sandostatin® (octreotide acetate) Immediate-Release Injection.

Learn More
learn more about


Find information and support specifically designed to help patients diagnosed with severe diarrhea and flushing associated with carcinoid syndrome, to access the materials and tools they need to help understand their disease, including nutritional info, recipes, patient stories, and more.